Discover Log In Sign Up
COO
The Cooper Companies, Inc.
Summary
Earnings Call Analysis
Valuation
Profitability
Financial Health
Positive High Gross Profit Margin
Positive Strong Operating and Net Profit Margins
Positive Strong Liquidity Ratios
Positive Low Debt Levels
Positive Record Revenues and Market Leadership
Positive Strategic Focus on Innovation
Positive Strong Margin Improvements
Positive Solid Guidance for FY2025
Positive Expansion in Growing Markets
Negative High P/E Ratio
Negative High EV/EBITDA Ratio
Negative Low Return on Equity
Negative Low Cash Ratio
Negative Unforeseen Softness in Demand
Negative Challenges in Manufacturing Capacity
Negative Competition and Market Dynamics
Negative Dependence on Key Innovations

Cooper Companies demonstrated robust performance with record revenues and strong market leadership in FY2024. However, challenges like unexpected demand softness and manufacturing capacity constraints could impact future growth. The company's focus on innovation and strategic expansion presents a positive outlook for FY2025, though it must navigate an increasingly competitive landscape.

Analysis Date: December 5, 2024
Last Updated: March 11, 2025

Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.

Graham Value Metrics

Benjamin Graham's value investing approach focuses on finding stocks with a significant margin of safety between their intrinsic value and market price.

Intrinsic Value

Estimated fair value based on Graham's formula

$79.49

Current Market Price: $73.32

IV/P Ratio: 1.08x (>1.0 indicates undervalued)

Margin of Safety

Gap between intrinsic value and market price

8.0%

Graham recommended a minimum of 20-30% margin of safety

Higher values indicate a greater potential discount to fair value

Graham Criteria Checklist

Benjamin Graham's value investing checklist for COO

Yes Positive earnings (5+ years)
No Dividend history (5+ years)
No P/E ratio ≤ 20 (35.73)
No P/B ratio ≤ 1.5 (1.83)
No Current ratio ≥ 2.0 (1.99x)
No Long-term debt < Net current assets (2.52x)
Yes Margin of safety (8.0%)
No COO does not meet all Graham criteria

ROE: 5.2023519540129115

ROA: 0.8533651879367052

Gross Profit Margin: 64.43680794196258

Net Profit Margin: 10.574010436553392

Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.

Strong Operating and Net Profit Margins

18.12%
Operating Profit Margin
10.07%
Net Profit Margin

The operating profit margin of 18.12% and net profit margin of 10.07% reflect effective cost management and a healthy bottom line.

Low Return on Equity

4.98%
Return on Equity

A return on equity of only 4.98% suggests that the company is not effectively utilizing its equity base to generate profits.

About Profitability Metrics

Profitability metrics measure a company's ability to generate earnings relative to its revenue, operating costs, and other relevant metrics. Higher values generally indicate better performance.

Return on Equity (ROE)

Measures how efficiently a company uses its equity to generate profits

5.20%

10% 15%

Higher values indicate better returns for shareholders

TTM (as of 2025-04-16)

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

0.85%

3% 7%

Higher values indicate better asset utilization

TTM (as of 2025-04-16)

Gross Profit Margin

Percentage of revenue retained after accounting for cost of goods sold

64.44%

20% 40%

Higher values indicate better efficiency in production

TTM (as of 2025-04-16)

Net Profit Margin

Percentage of revenue retained after accounting for all expenses

10.57%

8% 15%

Higher values indicate better overall profitability

TTM (as of 2025-04-16)

Strong Liquidity Ratios

1.91
Current Ratio
1.12
Quick Ratio

The current ratio of 1.91 and quick ratio of 1.12 indicate that the company has sufficient short-term assets to cover its short-term liabilities.

Low Debt Levels

0.32
Debt to Equity
0.21
Debt to Assets

With a debt-to-equity ratio of 0.32 and a debt-to-assets ratio of 0.21, the company maintains a conservative leverage position, reducing financial risk.

Low Cash Ratio

0.11
Cash Ratio

A cash ratio of only 0.11 indicates that the company may face challenges in meeting immediate liabilities with cash reserves.

About Financial Health Metrics

Financial health metrics assess a company's ability to meet its financial obligations and its overall financial stability.

Debt to Equity Ratio

Total debt divided by total equity

0.31x

1.0x 2.0x

Lower values indicate less financial leverage and risk

Less than 1.0 is conservative, 1.0-2.0 is moderate, >2.0 indicates high risk

Q1 2025

Current Ratio

Current assets divided by current liabilities

1.99x

1.0x 2.0x

Higher values indicate better short-term liquidity

Less than 1.0 is concerning, 1.0-2.0 is adequate, greater than 2.0 is good

Q1 2025

Record Revenues and Market Leadership

$3.9 billion
Total Revenue FY2024
19%
Non-GAAP EPS Growth

Cooper Companies reported all-time record revenues of $3.9 billion for fiscal 2024, driven by both CooperVision and CooperSurgical. The company maintained its position as the number one contact lens company in the world, showcasing strong growth in silicone hydrogel dailies and torics.

Strategic Focus on Innovation

Expected 40% growth in FY2025
Myopia Management Growth

The company is heavily focused on innovation, with plans to increase the availability of its innovative products and launch new ones. This includes the MyDay Energys lens and advancements in the myopia management sector.

Strong Margin Improvements

66.9%
Gross Margin Q4 FY2024
130 basis points
Operating Margin Improvement

Cooper Companies demonstrated strong margin improvements in FY2024, with consolidated operating income increasing by 16.2% and overall gross margins improving to 66.9%.

Unforeseen Softness in Demand

The company experienced unexpected softness in demand towards the end of Q4, particularly in the U.S. market, which raised concerns about potential volatility in sales.

Challenges in Manufacturing Capacity

Despite strong demand for MyDay products, the company faces challenges in meeting this demand due to manufacturing capacity constraints, which could limit growth potential in the short term.

Solid Guidance for FY2025

6% to 8%
FY2025 Revenue Growth Guidance

The company has provided guidance indicating consolidated revenue growth of 6% to 8% for FY2025, which reflects confidence in continued market share gains and operational efficiency improvements.

Expansion in Growing Markets

High single-digit growth
Fertility Growth Rate FY2025

Cooper Companies is poised for growth in the fertility sector, driven by favorable macro trends such as increasing patient awareness and improving access to treatment, with an expectation of organic growth in the mid-single digits for CooperSurgical.

Competition and Market Dynamics

The competitive landscape in the contact lens market is intensifying, with competitors launching new products that may challenge Cooper's market share and growth rates, highlighting the need for continued innovation.

Dependence on Key Innovations

The company's growth is heavily reliant on the success of key product launches such as MyDay and MiSight. Any delays or challenges in these product lines could impact future revenues.

Home Screener Search Profile

During the beta period, we're currently displaying stocks from the S&P 500 index only. More stocks will be added soon.

Loading...